Clinical Trials Browser

Phase 4 × Completed × pegfilgrastim × Clear all

NCT04781959 2025-03-21

A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy

Phase 4 Completed

Breast Neoplasms

NCT03511378 2021-06-15

Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer

Phase 4 Completed

138 enrolled 13 charts

Breast Neoplasms

NCT02782845 2016-11-21

An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)

Phase 4 Completed

Lymphoma, Non-Hodgkin

NCT02805153 2016-06-20

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy

Phase 4 Completed

Breast Neoplasms

NCT02805218 2016-06-20

PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy

Phase 4 Completed

Lymphoma

NCT02805166 2016-06-17

PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy

Phase 4 Completed

Other solid neoplasm

Malignant Solid Tumors

NCT00277160 2010-10-08

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Phase 4 Completed

BreastGynecologicLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neutropenia, Ovarian Neoplasms

NCT00115206 2009-04-06

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Fever, Neutropenia